Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01439152
Recruitment Status : Completed
First Posted : September 23, 2011
Last Update Posted : July 9, 2021
Information provided by (Responsible Party):